产品名称

Dasatinib - BMS 354825 | Sprycel

产品货号

Axon 1392 CAS [302962-49-8] MF C22H26ClN7O2SMW 488.01 Purity: 99% Soluble in DMSO Description Orally active dual BCR-ABL and Src family tyrosine kinases inhibitor. KEYWORDS: Dasatinib | supplier | Bcr-Abl/Src inhibitor | BMS 354825 | Sprycel | BMS354825 | BMS-354825 | CAS [302962-49-8] | Non Selective (Phosphorylation Substrates) | BCR-ABL | SRC | Inhibitor | Enzymes

产品价格

现货询价，电话：010-67529703

产品规格

产品品牌

axonmedchem

产品概述

产品详情

Dasatinib - BMS 354825 | Sprycel

Based on 18 reference(s) in Google Scholar 9 10 18

Axon 1392

CAS [302962-49-8]

MF C22H26ClN7O2S
MW 488.01

Purity: 99%
Soluble in DMSO

Dasatinib

Description

Orally active dual BCR-ABL and Src family tyrosine kinases inhibitor.

KEYWORDS: Dasatinib | supplier | Bcr-Abl/Src inhibitor | BMS 354825 | Sprycel | BMS354825 | BMS-354825 | CAS [302962-49-8] | Non Selective (Phosphorylation Substrates) | BCR-ABL | SRC | Inhibitor | Enzymes

M Talpaz et al. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N. Engl. J. Med 2006, 354(24), 2531–41.

JM Goldman, JV Melo. BCR-ABL in Chronic Myelogenous Leukemia - How Does It Work? Acta Haematol 2008, 119, 212-217.

Talpaz, M. et al. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N. Engl. J. Med. 2006, 354(24), 2531-2541.

List of publications using Dasatinib (Axon 1392) purchased from Axon Medchem

Cell Signaling & Oncology BCR-ABL SRC Oncogene Fusion Proteins EC 2.7.10.1

Bcr-Abl and Src tyrosine kinase inhibitor

Chemical name

N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide

Parent CAS No.

[302962-49-8]

产品资料